These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 19164583

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
    Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM, Greig NH.
    J Neurosci Res; 2003 Jun 01; 72(5):603-12. PubMed ID: 12749025
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.
    Kim DS, Choi HI, Wang Y, Luo Y, Hoffer BJ, Greig NH.
    Cell Transplant; 2017 Sep 01; 26(9):1560-1571. PubMed ID: 29113464
    [Abstract] [Full Text] [Related]

  • 5. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
    Ban K, Kim KH, Cho CK, Sauvé M, Diamandis EP, Backx PH, Drucker DJ, Husain M.
    Endocrinology; 2010 Apr 01; 151(4):1520-31. PubMed ID: 20172966
    [Abstract] [Full Text] [Related]

  • 6. The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia.
    Chen F, Wang W, Ding H, Yang Q, Dong Q, Cui M.
    J Neuroinflammation; 2016 Aug 26; 13(1):204. PubMed ID: 27566245
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease.
    Yuan Z, Li D, Feng P, Xue G, Ji C, Li G, Hölscher C.
    Eur J Pharmacol; 2017 Oct 05; 812():82-90. PubMed ID: 28666800
    [Abstract] [Full Text] [Related]

  • 10. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T.
    Breast Cancer Res Treat; 2012 Apr 05; 132(2):449-61. PubMed ID: 21638053
    [Abstract] [Full Text] [Related]

  • 11. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
    Li Y, Bader M, Tamargo I, Rubovitch V, Tweedie D, Pick CG, Greig NH.
    J Neurochem; 2015 Dec 05; 135(6):1203-1217. PubMed ID: 25982185
    [Abstract] [Full Text] [Related]

  • 12. Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats.
    Darsalia V, Mansouri S, Ortsäter H, Olverling A, Nozadze N, Kappe C, Iverfeldt K, Tracy LM, Grankvist N, Sjöholm Å, Patrone C.
    Clin Sci (Lond); 2012 May 01; 122(10):473-83. PubMed ID: 22150224
    [Abstract] [Full Text] [Related]

  • 13. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
    Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ.
    J Biol Chem; 2003 Jan 03; 278(1):471-8. PubMed ID: 12409292
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 colon cancer cells.
    Koehler JA, Kain T, Drucker DJ.
    Endocrinology; 2011 Sep 03; 152(9):3362-72. PubMed ID: 21771884
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia.
    Lee CH, Yan B, Yoo KY, Choi JH, Kwon SH, Her S, Sohn Y, Hwang IK, Cho JH, Kim YM, Won MH.
    J Neurosci Res; 2011 Jul 03; 89(7):1103-13. PubMed ID: 21472764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.